Dr Fieke Froeling

Dr Fieke Froeling is a Medical Oncologist and translational cancer researcher at the University of Glasgow with an overall research focus on tumour-host interactions and therapeutic development for pancreatic cancer. She joined the University of Glasgow and CRUK Scotland Institute in 2020 to start her translational research group.

Using well-annotated patient samples, routinely collected health care data, and patient-derived pre-clinical model systems her research aims to understand the complex dynamics of tumour-host interactions in pancreatic cancer, and identify novel therapeutic approaches with candidate biomarkers that can be tested in clinical trials.

Clinically, she works as a Medical Oncologist at the Beatson West of Scotland Cancer, is the pancreatic cancer lead of the Glasgow Experimental Cancer Medicine Centre, is principal investigator of multiple clinical trials, leads the national molecular tumour board for Precision-Panc, and co-leads the UK novel therapeutics working group for pancreatic cancer.  Overall, this allows her to focus on developing personalised therapeutic strategies that emanate from discoveries in both basic science and reverse translation from clinical observation.